Methotrexate and emerging therapies

Clinical and Experimental Rheumatology

Volumn 17, Issue 6 SUPPL. 18, 1999, Pages

  Kremer, J M ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Combination therapy; Methotrexate; Rheumatoid arthritis

Indexed keywords

CYCLOSPORIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADVERSE DRUG REACTION; ARTICLE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; HUMAN; LIVER TOXICITY; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; HUMANS; METHOTREXATE;

EID: 0032739527     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. KREMER JM, LEE JK: The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum 1986; 29: 822-31.
2. WEINBLATT ME, COBLYN JS, FOX DA, et al.: Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 1985; 312: 818-22.
3. WEINBLATT ME, WEISSMAN BN, HOLDSWORTH DE, et al.: Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis: 84 month update. Arthritis Rheum 1992; 35:129-37.
4. FURST DE, ERIKSON N, CLUTE L, et al.: Adverse experience with methotrexate during 176 weeks of a long-term prospective trial in patients with rheumatoid arthritis. J Rheumatol 1990; 17: 1628-35.
5. KREMER JM: Safety, efficacy and mortality in a long-term cohort of patients with RA on methotrexate: Follow-up after a mean of 13.3 years. Arthritis Rheum 1997; 40: 984-5.
6. KREMER JM, LEE JK: A long-term prospective study of the use of methotrexate in rheumatoid arthritis: Update after a mean of 53 months. Arthritis Rheum 1988; 31: 577-84.
7. KREMER JM, PHELPS CT: Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis: Update after a mean of 90 months. Arthritis Rheum 1992; 35: 138-45.
8. WEINBLATT ME, KAPLAN H, GERMAIN BF, et al.: Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis: A thirty-six-week, double-blind trial. Arthritis Rheum 1990; 33: 330-8.
9. WEINBLATT ME, TRENTHAM DE, FRASER PA, et al.: Long-term prospective trial of low dose methotrexate in rheumatoid arthritis. Arthritis Rheum 1988; 31: 167-75.
10. KREMER JM, ALARCÓN GS, LIGHTFOOT RW, et al.: Methotrexate for rheumatoid arthritis: Suggested guidelines for monitoring liver toxicity. Arthritis Rheum 1994; 37: 316-28.
11. KREMER JM, FURST D, WEINBLATT ME, et al.: Significant changes in serum AST across hepatic histological biopsy grades: An analysis of 3 prospective cohorts on methotrexate therapy for rheumatoid arthritis. J Rheumatol 1996; 23:459-61.
12. ALARCÓN GS, KREMER JM, MACALUSO M, et al.: Risk factors associated with lung injury in methotrexate-treated rheumatoid arthritis patients: A multicenter, case-control study. Ann Intern Med 1997; 127: 356-64.
13. KREMER JM, ALARCÓN GS, WEINBLATT ME, et al.: Clinical, laboratory, radiographic and histopathologic features of methotrexate lung injury in patients with rheumatoid arthritis: A multi-center study with literature review. Arthritis Rheum 1997; 40: 1829-37.
14. MIOSSEC P, VAN DEN BERG W: Review: TH1/ TH2 cytokine balance in arthritis. Arthritis Rheum 1997; 12: 2105-15.
15. O'DELL JR, HAIRE CE, ERICKSON N et al.: Treatment of rheumatoid arthritis with methotrexate, sulfasalazine and hydroxychloroquine, or a combination of these medications. N Engl J Med 1996; 334: 1287-91.
16. TUGWELL P, PINCUS T, YOCUM D et al.: Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995; 333: 137-41.
17. CRONSTEIN BN: Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum 1996; 39: 1951-60.
18. KREMER JM: Possible mechanisms of action of methotrexate in patients with rheumatoid arthritis. Br J Rheumatol 1995; 34 (Suppl.): 26-9.
19. GEORGESCU L, QUINN GC, SCUWARTZMAN S et al.: Lymphoma in patients with rheumatoid arthritis: Association with the disease state or methotrexate treatment. Semin Arthritis Rheum 1997; 26: 794.
20. GRIDLEY G, MCLAUGHLIN JK, EKBOM A et al.: Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993; 85: 307-11.
21. WILLIAMS HJ, WARD JR, READING JC et al.: Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 1992; 35: 259-69.